Ignite Creation Date:
2024-05-06 @ 2:18 PM
Last Modification Date:
2024-10-26 @ 1:28 PM
Study NCT ID:
NCT04278859
Status:
UNKNOWN
Last Update Posted:
2020-06-16
First Post:
2020-02-18
Brief Title:
Safety Tolerability and Pharmacokinetics of a Recombinant Humanized mAb Specific to B-and T-Lymphocyte Attenuator BTLA for Injection in Subjects With Advanced Malignancies
Sponsor:
Shanghai Junshi Bioscience Co Ltd
Organization:
Shanghai Junshi Bioscience Co Ltd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Advanced Solid Tumor |
Keywords: